Participants

5AM Ventures
7 Hills Pharma
Absco Therapeutics
Aera Therapeutics
Aitia
Alesta Therapeutics
Alexandria Real Estate Equities
Alnylam Pharmaceuticals
Altoida
Aquilo Partners
Arc Fusion
Arcturus Therapeutics
Arrakis Therapeutics
AstraZeneca
Bectas Therapeutics
BIAL Biotech
Biogen
BiotechTV
Blackbird Laboratories
Bluejay Therapeutics
Breakthru Medicine
Broad Institute
CBT Advisors
Chiesi USA
Citizens Private Bank
Clayton Bio Communications
Corsera Health
DaCapo Brainscience
Definium Therapeutics
Delix Therapeutics
Delphia Therapeutics
DLA Piper
Draig Therapeutics
DUB Therapeutics
Eikoinizo Therapeutics
EMD Serono
EnPlusone Biosciences

Entact Bio
Entrada Therapeutics
Enveda
Evotec
Evvy
Expedition Medicines
Flagship Pioneering
Flux Therapeutics
Foreground Capital
Gallop Oncology
GATC Health
Genepool Networks
General Proximity
Geron
GrayBella Capital
Green Room Communications
Grove BioPharma
GT Biosciences
HDAX Therapeutics
Hengrui Pharma
Hevolution
Ilios Therapeutics
Ipsen
Jefferson River Capital
Kailera Therapeutics
Kynexis Therapeutics
LB Pharmaceuticals
LIBRIS Innovations
Lily Ventures
Luminary Therapeutics
Lumira Ventures
Lytica Therapeutics
Manifold Bio
Martrisome Bio
MassBio
Merck
Merz Therapeutics
Mestag Therapeutics
Monte Rosa Therapeutics

Morphoceuticals
MResult
N=1 Collaborative
Neptune Bio
Neurvati Neurosciences
Neurosterix
Normunity
Novita Pharmaceuticals
Nucleate
NuCyRNA Therapeutics
Otsuka Pharmaceutical
OutSee
Oxford Finance
PathAI
Philips Ventures
Pretzel Therapeutics
ProFound Therapeutics
Progentos Therapeutics
PxB Fund
RA Ventures
Reverb Therapeutics
Q32 Bio
Sante
Satellite Bio
Seismic Therapeutics
Sidley
Souffle Therapeutics
Spur Therapeutics
SpyBiotech
Syntis Bio
Telomere Therpeutics
Tensor Bio
Third Rock Ventures
Tiller Therapeutics
Tract Bio
Two Bear Capital
Versatope Therapeutics
Vertex Ventures HC
WilmerHale
Xilio Therapeutics